UBS Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Sell |
272,861
-234,842
| -46% | -$2.65M | ﹤0.01% | 3461 |
|
|
2025
Q1 | $5.86M | Buy |
507,703
+133,072
| +36% | +$1.54M | ﹤0.01% | 2837 |
|
|
2024
Q4 | $3.17M | Buy |
374,631
+331,202
| +763% | +$2.81M | ﹤0.01% | 3343 |
|
|
2024
Q3 | $503K | Buy |
43,429
+30,023
| +224% | +$348K | ﹤0.01% | 4090 |
|
|
2024
Q2 | $158K | Sell |
13,406
-15,111
| -53% | -$178K | ﹤0.01% | 4706 |
|
|
2024
Q1 | $338K | Buy |
28,517
+1,413
| +5% | +$16.8K | ﹤0.01% | 4363 |
|
|
2023
Q4 | $332K | Buy |
27,104
+4,838
| +22% | +$59.3K | ﹤0.01% | 4268 |
|
|
2023
Q3 | $214K | Buy |
22,266
+6,397
| +40% | +$61.6K | ﹤0.01% | 4227 |
|
|
2023
Q2 | $143K | Buy |
15,869
+9,123
| +135% | +$82.1K | ﹤0.01% | 4685 |
|
|
2023
Q1 | $53K | Sell |
6,746
-2,888
| -30% | -$22.7K | ﹤0.01% | 5331 |
|
|
2022
Q4 | $65.1K | Buy |
9,634
+8,402
| +682% | +$56.8K | ﹤0.01% | 5375 |
|
|
2022
Q3 | $18K | Buy |
1,232
+168
| +16% | +$2.46K | ﹤0.01% | 6432 |
|
|
2022
Q2 | $10K | Sell |
1,064
-41,929
| -98% | -$394K | ﹤0.01% | 6929 |
|
|
2022
Q1 | $634K | Sell |
42,993
-10,570
| -20% | -$156K | ﹤0.01% | 3596 |
|
|
2021
Q4 | $708K | Buy |
53,563
+20,335
| +61% | +$269K | ﹤0.01% | 3721 |
|
|
2021
Q3 | $580K | Buy |
33,228
+28,906
| +669% | +$505K | ﹤0.01% | 3635 |
|
|
2021
Q2 | $104K | Sell |
4,322
-6,454
| -60% | -$155K | ﹤0.01% | 4813 |
|
|
2021
Q1 | $277K | Buy |
10,776
+9,007
| +509% | +$232K | ﹤0.01% | 4301 |
|
|
2020
Q4 | $34K | Buy |
1,769
+1,011
| +133% | +$19.4K | ﹤0.01% | 5526 |
|
|
2020
Q3 | $10K | Sell |
758
-3,557
| -82% | -$46.9K | ﹤0.01% | 5974 |
|
|
2020
Q2 | $52K | Sell |
4,315
-3,196
| -43% | -$38.5K | ﹤0.01% | 4984 |
|
|
2020
Q1 | $57K | Sell |
7,511
-9,882
| -57% | -$75K | ﹤0.01% | 4844 |
|
|
2019
Q4 | $310K | Buy |
17,393
+6,682
| +62% | +$119K | ﹤0.01% | 4277 |
|
|
2019
Q3 | $124K | Buy |
10,711
+8,605
| +409% | +$99.6K | ﹤0.01% | 4710 |
|
|
2019
Q2 | $47K | Buy |
2,106
+1,621
| +334% | +$36.2K | ﹤0.01% | 5120 |
|
|
2019
Q1 | $14K | Buy |
+485
| New | +$14K | ﹤0.01% | 5751 |
|
|
2018
Q4 | – | Sell |
-660
| Closed | -$14K | – | 7137 |
|
|
2018
Q3 | $14K | Sell |
660
-2,454
| -79% | -$52.1K | ﹤0.01% | 6080 |
|
|
2018
Q2 | $25K | Buy |
3,114
+2,969
| +2,048% | +$23.8K | ﹤0.01% | 5618 |
|
|
2018
Q1 | $1K | Sell |
145
-1,446
| -91% | -$9.97K | ﹤0.01% | 6739 |
|
|
2017
Q4 | $16K | Buy |
+1,591
| New | +$16K | ﹤0.01% | 5759 |
|
|
2017
Q3 | – | Sell |
-1,506
| Closed | -$11K | – | 6834 |
|
|
2017
Q2 | $11K | Sell |
1,506
-801
| -35% | -$5.85K | ﹤0.01% | 5769 |
|
|
2017
Q1 | $18K | Buy |
2,307
+1,398
| +154% | +$10.9K | ﹤0.01% | 5288 |
|
|
2016
Q4 | $6K | Sell |
909
-285
| -24% | -$1.88K | ﹤0.01% | 6183 |
|
|
2016
Q3 | $8K | Sell |
1,194
-388
| -25% | -$2.6K | ﹤0.01% | 5988 |
|
|
2016
Q2 | $15K | Buy |
+1,582
| New | +$15K | ﹤0.01% | 5627 |
|
|
2016
Q1 | – | Sell |
-53
| Closed | -$3K | – | 6773 |
|
|
2015
Q4 | $3K | Sell |
53
-269
| -84% | -$15.2K | ﹤0.01% | 6477 |
|
|
2015
Q3 | $16K | Buy |
+322
| New | +$16K | ﹤0.01% | 5617 |
|